Homeless Overdose Prevention- Expansion
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
Homeless Overdose Prevention - Expansion (HOPE), tests implementation of overdose education and naloxone distribution (OEND), a program that targets homeless experienced Veterans at risk for overdose, including Veterans in community-based supportive housing. HOPE sites will receive a playbook that offers step-by-step instructions, tools, templates, and checklists tailorable to site needs; sites will also receive performance feedback about their performance relative to a standard or benchmark.
Eligibility criteria
Qualifiers
Veterans enrolled in HUD-VASH at risk for opioid overdose (based on existing HOPE algorithms aligned with Pharmacy Benefit Manager data definitions), drawing from VA administrative data.
Disqualifiers
Not flagged by existing HOPE algorithms
Not currently enrolled in HUD-VASH
Is not a patient at a participating site of the implementation trial
Trial design
Treatments tested in this trial
- Homeless Overdose Prevention- Expansion (HOPE) - Low Intensity
- Homeless Overdose Prevention- Expansion (HOPE) - High Intensity
Treatment groups
1,200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov